Related Issuers
by Stephen Carter
May 03, 2022 11:54 AM ET
Moody's/S&P/Fitch rate Kepler SpA (Biofarma Group) EUR345m 144A/Reg S sr sec FRN due 2029 (7y) B3/B-/B+ (stable/stable/stable). Via BNP+.